Dine to Donate Night at Texas Roadhouse to benefit Leukemia and Lymphoma Society

« Back to Events
This event has passed.
Dine to Donate Night at Texas Roadhouse to benefit Leukemia and Lymphoma Society
July 28, 2014 4:00 pm
August 28, 2014 10:00 pm
Chris Dingman
July 16, 2014
Texas Roadhouse
Google Map
1000 US Rt. 9 S, Parlin, NJ, 08859, United States

Join Team Cindy’s Stars for DINE TO DONATE Night at Texas Roadhouse in Old Bridge, NJ to benefit the Leukemia and Lymphoma Society.

Simply bring a copy of the flyer to Texas Roadhouse (located at 1000 US Rte. 9 N in Parlin, NJ) on Monday night, July 28, 2014 from 4pm-10PM and Texas Roadhouse will donate 10% of your entire check to LLS.

In addition, we will be holding a raffle with prizes to be determined that will also benefit LLS. Donated prizes include Dinner for 2 from Texas Roadhouse as well as a package of (4) Somerset Patriots baseball tickets good for any game in 2015.

Team Cindy’s Stars was formed as a LIGHT THE NIGHT WALK team in 2009 in memory of Lucinda Dingman who succumbed to Leukemia in February of that year. Since 2009, Team Cindy’s Stars has raised over $15,000 for LLS. This year, we will once again by walking in the Light the Night Walk in Long Branch, NJ on Saturday, Oct 18. Our team goal for this fundraising season is a generous $5,000.

Since 2009, our team has grown and we now walk with over 20 people who walk in memory of either Lucinda or other loved ones who have been lost to Leukemia and Lymphoma.

LLS has an important mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

Today, LLS is the world’s largest voluntary health agency dedicated to finding cures for leukemia, lymphoma, myeloma and other blood cancers. To date, LLS has invested nearly $ 1 billion in research to advance therapies and save lives. Thanks to research, survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s. Despite these advances, about one third of patients with a blood cancer still do not survive even five years after their diagnosis, which is why more funding is needed to bring better therapies to patients, and faster.